Drug Type Small molecule drug |
Synonyms KROS-102 |
Target |
Mechanism GITR inhibitors(Glucocorticoid-induced tumor necrosis factor receptor-related protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | ![]() | 15 Mar 2024 |
Glioblastoma | Preclinical | US | ![]() | 15 Mar 2022 |